4D CT analysis of organs at risk (OARs) in stereotactic radiotherapy-Reference-Cited by-同舟云学术

4D CT analysis of organs at risk (OARs) in stereotactic radiotherapy

Published:2020-10 Issue: Volume:151 Page:10-14
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Nardone Valerio^ORCID,Giugliano Francesca Maria,Reginelli Alfonso,Sangiovanni Angelo,Mormile Maria,Iadanza Luciano,Cappabianca Salvatore,Guida Cesare^ORCID

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference32 articles.

1. Extracranial stereotactic radioablation: physical principles;Papiez;Acta Oncol,2003

2. Stereotactic body radiation therapy for inoperable early stage lung cancer;Timmerman;JAMA,2010

3. Which is the optimal biologically effective dose of stereotactic body radiotherapy for Stage I non-small-cell lung cancer? A meta-analysis;Zhang;Int J Radiat Oncol Biol Phys,2011

4. Shioyama Y, Onishi H. Clinical outcomes of stereotactic body radiotherapy for patients with stage I small-cell lung cancer: analysis of a subset of the Japanese radiological society multi-institutional SBRT Study Group Database. 2018;17:1533033818783904.

5. The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer;Tini;Expert Rev Anticancer Ther,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosimetric impact of respiratory motion on proximal bronchial tree during lung cancer stereotactic body radiation therapy: A patient-specific phantom study;Journal of Radiation Research and Applied Sciences;2024-09

2. New perspectives on inoperable early-stage lung cancer management: Clinicians, physicists, and biologists unveil strategies and insights;The Journal of Liquid Biopsy;2024-09

3. Cardiorespiratory motion characteristics and their dosimetric impact on cardiac stereotactic body radiotherapy;Medical Physics;2024-07-12

4. Quantifying dose uncertainties resulting from cardiorespiratory motion in intensity-modulated proton therapy for cardiac stereotactic body radiotherapy;Frontiers in Oncology;2024-07-08

5. And Yet It Moves: Clinical Outcomes and Motion Management in Stereotactic Body Radiation Therapy (SBRT) of Centrally Located Non-Small Cell Lung Cancer (NSCLC): Shedding Light on the Internal Organ at Risk Volume (IRV) Concept;Cancers;2024-01-04